Nicole LaBrosse
Finanzdirektor/CFO bei HALOZYME THERAPEUTICS, INC.
Vermögen: 595 361 $ am 30.04.2024
Aktive Positionen von Nicole LaBrosse
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| HALOZYME THERAPEUTICS, INC. | Finanzdirektor/CFO | 02.02.2022 | - |
| Comptroller/Controller/Auditor | 01.01.2017 | 02.02.2022 | |
| Direktor/Vorstandsmitglied | 01.01.2017 | 01.01.2020 | |
| ANTARES PHARMA, INC. | Direktor/Vorstandsmitglied | 24.05.2022 | - |
Karriereverlauf von Nicole LaBrosse
Ehemalige bekannte Positionen von Nicole LaBrosse
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
PricewaterhouseCoopers LLP
 PricewaterhouseCoopers LLP Miscellaneous Commercial ServicesCommercial Services PricewaterhouseCoopers LLC provides assurance, tax and advisory services. Its services include audit and assurance, consulting, deals, human resources, legal, tax, and family business. The firm also offers accountability, risk management, structuring, mergers and acquisitions, and performance and process improvement. The company was founded in 1998 and is headquartered in Buffalo, NY. | Comptroller/Controller/Auditor | 01.01.2004 | 01.01.2015 |
Ausbildung von Nicole LaBrosse
| McCallum Graduate School of Business | Graduate Degree |
| Bentley University | Graduate Degree |
Statistik
International
| Vereinigte Staaten | 5 |
| Vereinigtes Königreich | 2 |
Operativ
| Comptroller/Controller/Auditor | 2 |
| Director/Board Member | 2 |
| Graduate Degree | 2 |
Sektoral
| Health Technology | 3 |
| Consumer Services | 3 |
| Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| HALOZYME THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
PricewaterhouseCoopers LLP
PricewaterhouseCoopers LLP Miscellaneous Commercial ServicesCommercial Services PricewaterhouseCoopers LLC provides assurance, tax and advisory services. Its services include audit and assurance, consulting, deals, human resources, legal, tax, and family business. The firm also offers accountability, risk management, structuring, mergers and acquisitions, and performance and process improvement. The company was founded in 1998 and is headquartered in Buffalo, NY. | Commercial Services |
Antares Pharma, Inc.
 Antares Pharma, Inc. Pharmaceuticals: MajorHealth Technology Antares Pharma, Inc. is a specialty pharmaceutical company, which engages in the development and commercialization of pharmaceutical products and technologies in targeted therapeutic areas. Its products include XYOSTED injection, OTREXUP injection for subcutaneous use, and Sumatriptan injection. The company was founded in February 1979 and is headquartered in Ewing, NJ. | Health Technology |
- Börse
- Insiders
- Nicole LaBrosse
- Erfahrung
